Pulse Biosciences (PLSE) Shares Outstanding (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Shares Outstanding (Entity) of $67.8 million for Q4 2025, up 2.9% year-over-year from $65.9 million in Q4 2024, and little changed quarter-over-quarter from $67.7 million in Q3 2025.
Pulse Biosciences (PLSE) Shares Outstanding (2015 - 2026) Analysis & Trends
Pulse Biosciences' Shares Outstanding (Entity) history runs 11 years deep, the most recent figure standing at $67.8 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 2.9% year-over-year to $67.8 million; the TTM figure through Dec 2025 stood at $67.8 million (up 2.9% YoY), while the FY2025 annual figure was $67.8 million, up 2.9% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $67.8 million, roughly flat from $67.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $67.8 million in Q4 2025, with the low at $26.4 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $49.8 million (2023), against an average of $47.9 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) jumped 48.1% in 2023, then grew 2.9% in 2025.
- Pulse Biosciences' Shares Outstanding (Entity) stood at $29.7 million in 2021, then increased by 25.3% to $37.2 million in 2022, then surged by 48.1% to $55.1 million in 2023, then climbed by 19.55% to $65.9 million in 2024, then rose by 2.9% to $67.8 million in 2025.
- Business Quant data shows PLSE's Shares Outstanding (Entity) at $67.8 million in Q4 2025, $67.7 million in Q3 2025, and $67.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | 69.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.20 Mn |
| Dec 31, 2025 | 67.40 Mn |
| Sep 30, 2025 | 67.39 Mn |
| Jun 30, 2025 | 67.28 Mn |
| Mar 31, 2025 | 67.13 Mn |
| Dec 31, 2024 | 58.40 Mn |
| Sep 30, 2024 | 61.07 Mn |
| Jun 30, 2024 | 57.18 Mn |
| Mar 31, 2024 | 55.17 Mn |
| Dec 31, 2023 | 48.04 Mn |
| Sep 30, 2023 | 54.92 Mn |
| Jun 30, 2023 | 44.51 Mn |
| Mar 31, 2023 | 37.39 Mn |
| Dec 31, 2022 | 33.94 Mn |
| Sep 30, 2022 | 37.16 Mn |
| Jun 30, 2022 | 31.49 Mn |
| Mar 31, 2022 | 29.75 Mn |
| Dec 31, 2021 | 27.96 Mn |
| Sep 30, 2021 | 29.61 Mn |
| Jun 30, 2021 | 26.48 Mn |